FCA
VRCA icon

FinTrust Capital Advisors’s Verrica Pharmaceuticals VRCA Stock Holding History

FinTrust Capital Advisors’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$14.5K Buy
+1,000
New +$45K ﹤0.01% 869
2020
Q4 		– Sell
-1,000
Closed -$77K – 1156
2020
Q3 		$77K Buy
+1,000
New +$81.9K 0.02% 412

Other funds holding VRCA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

FinTrust Capital Advisors's VRCA Position: Q3 2024 in Review

FinTrust Capital Advisors opened a new position in Verrica Pharmaceuticals (VRCA) in Q3 2024: 1,000 shares worth $14.5K. The stake represents ﹤0.01% of the portfolio and ranks #869 among its holdings. This is a return to the name: FinTrust Capital Advisors previously reported a position in VRCA as recently as Q3 2020.

FinTrust Capital Advisors first reported a position in VRCA in Q3 2020 and has held it in 2 quarters since. The position peaked at $77K in Q3 2020. 79 funds tracked by Wall St. Rank hold VRCA as of Q3 2024.

  • FinTrust Capital Advisors held 1,000 shares of Verrica Pharmaceuticals worth $14.5K as of Q3 2024.
  • Verrica Pharmaceuticals was a new FinTrust Capital Advisors position in Q3 2024.
  • Verrica Pharmaceuticals made up ﹤0.01% of FinTrust Capital Advisors's portfolio in Q3 2024, its #869 holding.
  • FinTrust Capital Advisors first reported a position in Verrica Pharmaceuticals in Q3 2020 and has held it in 2 quarters since.
  • FinTrust Capital Advisors's Verrica Pharmaceuticals position peaked at $77K in Q3 2020.
  • 79 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.